Wang, Jing
Wang, Tianlong
Zhang, Han
Zhang, Qiaoni
Liu, Gang
Yan, Shujie
Wang, Qian
Teng, Yuan
Wang, Jian
Hu, Qiang
Ji, Bingyang
Funding for this research was provided by:
National High-level Hospital Clinical Research Funding (2023-GSP-GG-7)
Article History
Received: 3 September 2024
Accepted: 14 October 2024
First Online: 22 October 2024
Declarations
:
: This study was approved by the Ethics Committee of Fuwai Hospital (2023–2073). Informed consent will be obtained from all participants before enrollment, ensuring they understand the study’s purpose, procedures, risks, and benefits. Participants will be informed of their right to withdraw from the study at any time, and confidentiality of their data will be strictly protected.
: Not applicable.
: The authors declare no competing interests.
: The current protocol version is Version 4.0 (May 2024). The current informed consent version is Version 3.0 (May 2024). The first patient was enrolled on September 21, 2023. One hundered patients have been enrolled in this study so far. We expect to complete recruitment by December 2024. The results of primary and secondary outcomes will be published after the follow-up.